On Tuesday, Indian pharmaceutical company, Ranbaxy Laboratories, Ltd. announced that it had reached a settlement agreement with the U.S. Food and Drug Administration regarding its manufacturing practices.

Not only did the company announce its commitment to revitalizing its product manufacturing procedures, but it will also set aside $500 million to cover any future criminal and civil liability claims associated with an investigation by the U.S. Justice Department.

After the FDA banned more than 30 of Ranbaxy’s generic drug products in 2008 due to poor quality conditions at several of their production facilities, the company is now going the extra mile to strengthen its practices and procedures in order to protect the integrity of its data, as well as to comply with good manufacturing practices.

(Source: MSN Money Online News Center, AP article 12/20/11)


Frank M. Eidson P.A. has been tirelessly representing the rights of Central Florida victims since 1989.

$4.2 Million

Auto Accident

$2.3 Million

Workers Comp Case

$5.65 Million

Auto Accident

Free, No Obligation Case Review.

Fill out our contact form below for your free, no obligation case review.

  • This field is for validation purposes and should be left unchanged.

Help provide wounded servicemen and women with therapeutic outdoor adventures. Like our Facebook page and we'll contribute $1 to Wounded Warriors Outdoors.

Contact Our Orlando Attorney

If you have been injured in an accident, turn to Frank M. Eidson P.A. Whether your case is a simple collision or a complicated auto wrongful death case, contact personal injury lawyer Frank Eidson today to schedule your free consultation.